Latest Breaking News On - Lukasz kuryk - Page 1 : comparemela.com

/PRNewswire/ Targovax ASA (OSE: TRVX), a clinical stage immuno-oncology company developing immune activators to target hard-to-treat solid tumors, today.

Oystein sougLukasz kurykPrnewswire targovaxAndreas tinglumRenate birkeliLuis pazCorporate communications norwaySociety for immunotherapy of cancerLuis paz aresMedical oncologyHospital universitarioDirector clinical scienceAnnual meetingPre conference programsHealth care amp hospitalsMedical pharmaceuticals